UMIN ID: UMIN000001575
Registered date:15/12/2008
Uric acid Reduction Ameliorates Transition to End-stage renal disease Study (URATE Study)
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | hyperuricemia chronic kidney disease (CKD) |
| Date of first enrollment | 2008/12/01 |
| Target sample size | 660 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | administration of benzbromarone unadministration of benzbromarone |
Outcome(s)
| Primary Outcome | Death Doubling of serum creatinine Dialysis |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | -patient with contraindications to benzbromarone -patient who takes warfarin |
Related Information
| Primary Sponsor | Society for Research on chronic kidney disease and hyperuricemia |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Kidney Foundation, Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroyuki Matsuda |
| Address | 2-11-1 Kaga Itabashiku Tokyo Japan |
| Telephone | |
| URATE-Office@jhbri.com | |
| Affiliation | Teikyo University EBM Center |
| scientific contact | |
| Name | Syunya Uchida |
| Address | 2-11-1 Kaga Itabashiku Tokyo Japan |
| Telephone | |
| Affiliation | Teikyo University Department of internal medicine |